Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

A Randomised Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS or Low Blast AML: GFM's "pick a Winner" Trial, with the Impact of Somatic Mutations.

Lionel Ades,Nicolas Duployez,Agnes Guerci-Bresler,Kamel Laribi,Pierre Peterlin,Norbert Vey,Sylvain Thepot,Stefan Wickenhauser,Hacene Zerazhi,Aspassia Stamatoullas,Eric Wattel,Christian Recher,Andrea Toma,Sophie Dimicoli-Salazar,Thorsten Braun,Odile Beyne-Rauzy,Jean-Pierre Marolleau,Stephane Cheze,Sophie Park,Thomas Cluzeau,Stanislas Nimubona,Dominique Bordessoule,Riad Benramdane,Bruno Quesnel,Shanti Ame,Stephane de Botton,Fathia Chermat,Claude Preudhomme,Sylvie Chevret,Pierre Fenaux

British journal of haematology（2022）

Cited 8|Views33
No score
Key words
clinical trials,MDS,molecular biology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined